By Chibuike Oguh, Purvi Agarwal and Shashwat Chauhan

NEW YORK (Reuters) -Wall Street’s benchmark rose on Wednesday and a rally in tech stocks lifted the Nasdaq above the 20,000-point milestone for the first time, after a U.S. inflation report boosted expectations of a Federal Reserve interest rate cut.

The dipped, dragged by health insurers as U.S. lawmakers introduced a bill seen as crimping their profits.

Five of the 11 major S&P 500 sectors advanced, led by gains in communication services, technology and consumer discretionary services.

A Labor Department report showed U.S. consumer prices in November increased by the most in seven months, though broadly in line with market expectations.

The Dow Jones Industrial Average fell 99.27 points, or 0.22%, to 44,148.56, the S&P 500 gained 49.28 points, or 0.82%, to 6,084.19 and the gained 347.65 points, or 1.77%, to 20,034.89.

“Nasdaq is rallying on the prospect of a rate cut next week and has room to move higher,” said Peter Cardillo, chief market economist at Spartan Capital Securities.

Markets are pricing in more than a 96% chance the Fed will cut rates by 25 basis points next week, up from an 86% chance before the data, according to CME’s FedWatch Tool. Bets had risen following Friday’s employment report, which showed an uptick in unemployment alongside a surge in job growth.

The yield on benchmark U.S. 10-year notes rose 5.2 basis points to 4.271%.

“The equity market seems to be breathing a sigh of relief that this is another steady-as-she-goes report,” said Wasif Latif, chief investment officer at Sarmaya Partners in New Jersey. “There’s no surprises. It seems the equity market was braced for a higher than expected number.”

Tesla (NASDAQ:) shares climbed nearly 6% to a record high as the electric vehicle maker extended a rally in the wake of the U.S. presidential election.

Nvidia (NASDAQ:) and other megacap growth stocks, including Alphabet (NASDAQ:) and Amazon (NASDAQ:), also finished higher, adding between 1.2% and 5.5%. Apple (NASDAQ:) edged down 0.5%

Pharmacy benefit managers, including Cigna (NYSE:), CVS Health (NYSE:), and UnitedHealth Group (NYSE:), lost ground after a bipartisan group of lawmakers introduced a bill that would force health insurers or drug middlemen to divest their pharmacy businesses.

GameStop (NYSE:) gained 7.5% after the videogame retailer reported a profit for the third quarter on cost-saving efforts.

Broadcom (NASDAQ:) jumped 6.6% following a report that Apple is working with the company to develop its first server chip specially designed for artificial intelligence.

Macy’s (NYSE:) shed 0.8% after the department-store bellwether cut its annual profit forecast as persistent weakness in demand clouded its expectations for the holiday shopping season.

Advancing issues outnumbered decliners by a 1.27-to-1 ratio on the NYSE. On the Nasdaq, 2,287 stocks rose and 2,029 fell as advancing issues outnumbered decliners by a 1.13-to-1 ratio.

© Reuters. Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., December 10, 2024.  REUTERS/Brendan McDermid

The S&P 500 posted 22 new 52-week highs and 6 new lows while the Nasdaq Composite recorded 127 new highs and 118 new lows.

About 14.25 billion shares were traded across U.S. exchanges, compared with the 14.35 billion average for the last 20 sessions.


Source link

Best Brokers

Unmatched trading fees, generous bonuses, top notch Regulation Frame.

T&Cs Apply

Risk disclosure: All investments involve a degree of risk of some kind. Trading financial derivative products comes with a high risk of losing money rapidly due to leverage.

Top-Tier Regulations. Unmatched Spreads and Commissions. Trading View is available.

T&Cs Apply

Financial Spread Trades and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 84.7% of retail investor accounts lose money when trading CFDs with this provider.

Modern and Intuitive Interfaces, Solid Regulatory Frame, and excellent Trading Fees.

T&Cs Apply
Risk warning: Trading derivatives is highly speculative, carries an inherent risk of loss and is not suitable for all investors. Before trading, you are strongly advised to read and ensure that you understand the relevant risk disclosures and warnings.

Highly Regulated. Low Spreads and Commissions. Vast Account Options.

T&Cs Apply

Risk Warning: Trading derivatives carries significant risks. It is not suitable for all investors and if you are a professional client, you could lose substantially more than your initial investment.